August 24, 2022 8:08 a.m. EDT
(24/7 MARKET NEWS) – Bright Minds Biosciences (NASDAQ: DRUG) is trading is this morning’s premarket at $1.74, up $0.41 (+30.83%), on over 3.7 million shares.
Today’s price spike is the third even numbered day in a row to see a price spike.
The biotechnology company announced, last night, the pricing of its previously announced offering of an aggregate of 2,858,000 units at a price of $1.40 per Unit, for about $4 million in aggregate gross proceeds, with each Unit is comprised of one common share in the capital of the Company and one common share purchase warrant.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.